All Resources

March 19, 2025

IMC Response to the PMPRB’s March 2025 Guidelines Consultation

Learn more | View

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget

Learn more | View

Access to Medicine • January 30, 2025

Increasing Access to Innovative Medicines

2025 Alberta Budget

Learn more | View

Access to Medicine • January 30, 2025

Increasing Access to Innovative Medicines

2025 Ontario Budget

Learn more | View

Intellectual Property • November 06, 2024

Submission on Global Affairs Canada CUMSA Consultation

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • September 11, 2024

IMC Response to the PMPRB’s 2024 Discussion Guide on the Board’s Guidelines

Learn more | View

Access to Medicine • August 15, 2024

IMC Submission on Increasing Access to Innovative Medicines

Learn more | View

July 02, 2024

Submission on Proposed Patent Term Adjustment (PTA) Regulations

Learn more | View

Pharmacare • June 05, 2024

IMC Open Letter to Senators on Bill C‑64

Learn more | View

Pharmacare • May 23, 2024

IMC Submission to the Standing Committee of Health on Bill C-64

Learn more | View

Intellectual Property • April 16, 2024

IMC Response to Consultation on Scientific Research and Experimental Development

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View